Deciphering unique and shared interactions between the human gut microbiota and oral antidiabetic drugs.

ABSTRACT: The administration of oral antidiabetic drugs (OADs) to patients with type 2 diabetes elicits distinct and shared changes in the gut microbiota, with acarbose and berberine exhibiting greater impacts on the gut microbiota than metformin, vildagliptin, and glipizide. The baseline gut microbiota strongly associates with treatment responses of OADs.

SUBMITTER: Ren H 

PROVIDER: S-EPMC11170963 | biostudies-literature | 2024 Apr

REPOSITORIES: biostudies-literature